mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2019.00684
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Frontiers Media SA

Related search

FRI0566 Teriparatide and Alendronate Improved Bone Loss and Hyperalgesia in a Mouse Model of Osteoporosis

2017English

T49: Chinese Herbal Formula BSNXD Prevents Bone Loss by Modulating T Cells and Cytokine Production in the OVX-mouse Model for Postmenopausal Osteoporosis

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

mCSF-Induced Microglial Activation Prevents Myelin Loss and Promotes Its Repair in a Mouse Model of Multiple Sclerosis

Frontiers in Cellular Neuroscience
Molecular NeuroscienceCellular
2018English

RNAi-Mediated Silencing of Atp6i and Atp6i Haploinsufficiency Prevents Both Bone Loss and Inflammation in a Mouse Model of Periodontal Disease

PLoS ONE
Multidisciplinary
2013English

Up‐regulated CST5 Inhibits Bone Resorption and Activation of Osteoclasts in Rat Models of Osteoporosis via Suppression of the NF‐κB Pathway

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2019English

The Role of MicroRNAs in Osteoclasts and Osteoporosis

RNA Biology
Cell BiologyMolecular Biology
2014English

Alendronate Prevents Alveolar Bone Loss in Experimental Rat Periodontitis

Nihon Shishubyo Gakkai Kaishi (Journal of the Japanese Society of Periodontology)
2005English

Whole Body Vibration Training Attenuates Bone Loss in Osteoporosis: A Case Report

Journal of Osteoporosis and Physical Activity
2017English

Oral Weekly Ibandronate Prevents Bone Loss in Postmenopausal Women

Journal of Internal Medicine
Internal Medicine
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy